Business
Bio Spectrum
India & Australia develop precision nano-injection platform for breast cancer drug delivery
Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.
1 min |
February 2026
Bio Spectrum
Agilent opens India Refurbishment Centre in Manesar
Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.
1 min |
February 2026
Bio Spectrum
Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery
Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.
1 min |
February 2026
Bio Spectrum
Park Medi World buys KP Institute of Medical Sciences for Rs 245 Cr
Park Medi World Limited, North India's second largest chain of hospitals, has agreed to acquire KP Institute of Medical Sciences (KPIMS), in an all-cash transaction amounting to Rs 245 crore.
1 min |
February 2026
Bio Spectrum
146 Biosimilars in 25 Years: India at Global Scale
Biosimilars are an important part of modern therapeutics and a central component of India's shift beyond a generics-led pharmaceutical model.
8 min |
February 2026
Bio Spectrum
Decode Age raises Rs 14.48 Cr to advance longevity science and gut microbiome research
Bengaluru-based Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised Rs 14.48 crore in its Pre Series A funding round led by Dr Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India Limited.
1 min |
February 2026
Bio Spectrum
Havih Envirosciences announces partnership with Andhra Pradesh
Havih Envirosciences, a subsidiary of Maxwell Biosciences, has announced a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and production capabilities in the state.
1 min |
February 2026
Bio Spectrum
Biofabri and Bharat Biotech ink technology transfer agreement to advance global access to MTBVAC
Biofabri, a global human vaccine development company that is part of Spain-based Zendal group, and Bharat Biotech International Limited (BBIL) in Hyderabad, a global leader in vaccine innovation and manufacturing, have announced the signing of a Technology Transfer Agreement.
1 min |
February 2026
Bio Spectrum
IIT-D and AIIMS develop swallowable microdevice for microbiome study
Researchers at the Indian Institute of Technology (IIT) Delhi, and All India Institute of Medical Sciences (AIIMS) have developed an ingestible device that can sample bacteria directly from the small intestine, opening a new window into the human gut microbiome.
1 min |
February 2026
Bio Spectrum
Care ADHD expands global operations with first GCC in India
Care ADHD, one of the United Kingdom's fastest growing digital mental health companies and a key partner to the NHS, has announced the opening of its first Global Capability Centre (GCC) in India - Bengaluru.
1 min |
February 2026
Bio Spectrum
PM launches Ayush Mark, setting global quality benchmarks for India's traditional medicine
In a historic and visionary move that marks a defining moment for India's traditional medicine ecosystem, Prime Minister (PM) Narendra Modi has launched the Ayush Mark, establishing a globally aligned quality certification framework for Ayush products and services.
1 min |
February 2026
Bio Spectrum
US announces $50 B in awards to strengthen rural healthcare
The Centers for Medicare & Medicaid Services (CMS) has announced that all 50 states will receive awards under the Rural Health Transformation Program, a $50 billion initiative established under President Trump's Working Families Tax Cuts legislation (Public Law 119-21) to strengthen and modernise healthcare in rural communities across the country.
1 min |
February 2026
Bio Spectrum
Novo Nordisk launches world's most prescribed GLP-1 drug Ozempic in India
Novo Nordisk, a global healthcare company, has announced the launch of Ozempic (injectable semaglutide) in India.
1 min |
February 2026
Bio Spectrum
Vyome inches towards US FDA approval to enter $1B worth malignant fungating wound market
Vyome Holdings, Inc., a startup based both in the US & India, has announced the final results from an investigator-initiated Phase 2 proof of concept study of VT-1953 topical gel in people with malignant fungating wounds (MFW). VT-1953, a first-in-class immunomodulator for this indication, achieved both its primary & secondary endpoints.
1 min |
February 2026
Bio Spectrum
Symbiotec Pharmalab files DRHP with SEBI for IPO aggregating upto Rs 2180 Cr
Indore-based Symbiotec Pharmalab, a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms-organic chemistry, biotechnology and complex injectables, has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).
1 min |
February 2026
Bio Spectrum
BD Biosciences opens Centre of Excellence for Single-Cell Multiomics
BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson and Company), a global leader in life sciences, in collaboration with Delhi-based Institute of Genomics and Integrative Biology (IGIB), has announced the inauguration of its Centre of Excellence (COE) for Single-Cell Multiomics in India.
1 min |
February 2026
Bio Spectrum
Uruguay advances toward mercury-free dentistry
With the support of the Pan American Health Organization/World Health Organization (PAHO/WHO), Uruguay has strengthened its technical, environmental, and communication capacities for eliminating the use of dental amalgam, a material containing approximately 50 per cent mercury, an environmental contaminant that poses a risk to the workers who handle it.
1 min |
February 2026
Bio Spectrum
Dr Satya Prakash Dash steps in as new CEO of IKP Knowledge Park
Hyderabad-based bioincubator and life sciences park, IKP Knowledge Park has announced the appointment of Dr Satya Prakash Dash as the new Chief Executive Officer, bringing over 28 years of leadership in science, innovation and ecosystem building.
1 min |
February 2026
Bio Spectrum
World Bank supports improved health services in Salvador
The World Bank Board of Directors has approved a new operation to expand access to quality health, education, and social assistance services in Brazil's Municipality of Salvador, in the northeastern State of Bahia.
1 min |
February 2026
Bio Spectrum
Centre announces special dispensation to deep-tech startups in DSIR accreditation process
Union Minister of State (Independent Charge) for Science and Technology Dr Jitendra Singh has announced a major relaxation in the mandatory three-year survival condition for deep-tech startups to get recognition under the Industrial R&D Promotion Programme of Department of Scientific and Industrial Research (DSIR).
1 min |
February 2026
Bio Spectrum
NIT Rourkela secures projects worth Rs 1.82 Cr to strengthen international research engagement
National Institute of Technology (NIT) Rourkela has been awarded two research projects under the Scheme for Promotion of Academic and Research Collaboration (SPARC) of the Ministry of Education, Government of India, with a total sanctioned funding of over Rs 1.82 crore. Each project has a duration of two years.
1 min |
February 2026
Bio Spectrum
WHO reveals major equity gaps in human genomics research
The World Health Organization (WHO) has published a new global analysis of human genomics in clinical research, covering more than three decades of studies registered between 1990 and 2024.
1 min |
February 2026
Bio Spectrum
CEPI to fund Ph 3 trial for Moderna's mRNA pandemic influenza candidate
Norway-based Coalition for Epidemic Innovations (CEPI) will invest up to $54.3 million to support a pivotal Phase 3 clinical trial that aims to help advance Moderna's investigational mRNAbased H5 pandemic Preparedness influenza vaccine candidate, mRNA-1018, to licensure.
1 min |
February 2026
Bio Spectrum
Kashiv BioSciences secures Rs 648 Cr financing from UBI
Kashiv BioSciences, a biopharmaceutical company, has secured financing of Rs 648 crore from the Union Bank of India.
1 min |
February 2026
Bio Spectrum
S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat
The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.
1 min |
February 2026
Bio Spectrum
BioVaram to establish Centre for Excellence in Life Sciences in Hyderabad
In a path-breaking move, marking a significant leap in India's journey toward becoming a global innovation hub in line with Vision 2047, BioVaram (UR Advanced Therapeutics), a rapidly growing biotech startup incubated at ASPIRE-BiONEST, University of Hyderabad, has announced the establishment of a landmark Centre for Excellence in Life Sciences focusing on Tissue Engineering, Regenerative Medicine, and Cell and Gene Therapy.
1 min |
February 2026
Bio Spectrum
Senores Pharmaceuticals makes Rs 91 Cr acquisition of Apnar Pharma
Senores Pharmaceuticals has entered into a definitive agreement to acquire 100 per cent equity stake in Apnar Pharma, along with the acquisition of five Abbreviated New Drug Applications (ANDAs), marking a significant milestone in Senores' growth strategy across regulated pharmaceutical markets.
1 min |
February 2026
Bio Spectrum
Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits
US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.
1 min |
February 2026
Bio Spectrum
Revvity introduces AI-augmented design platform for molecular and materials discovery
US-based Revvity, Inc. has announced the introduction of its forthcoming Signals Xynthetica Models-as-a Service (MaaS) AI offering within the Revvity Signals platform.
1 min |
February 2026
Bio Spectrum
Intas Pharmaceuticals collaborates with IntegriMedical
Ahmedabad-based Intas Pharmaceuticals has entered into an exclusive agreement with IntegriMedical, the technology leader behind India's first NeedleFree Injection System (N-FIS), to introduce this revolutionary technology for use in IVF and gynaecology treatments across India. This marks a significant milestone in IVF and women's health.
1 min |